FDA Inspection 1158786 — Vitalant
The FDA completed an inspection of Vitalant on Nov 30, 2021 in Glenview, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 30, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Glenview, IL (United States)